Relating to costs associated with ante-mortem testing of breeder deer for chronic wasting disease.
Relating to disease control and breeder deer.
Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to costs associated with the destruction of certain deer.
Relating to costs associated with the destruction of certain deer.
Relating to prior authorization for prescription drug benefits related to the treatment of chronic and autoimmune diseases.
Relating to prior authorization for prescription drug benefits related to the treatment of chronic and autoimmune diseases.
Relating to the regulation of licensed dog and cat breeders.
Relating to limitations on public health directives issued during a state of disaster or outbreak of a communicable disease.